Overview
Rhonda M. Merwin, PhD, is an Associate Professor in the Department of Psychiatry and Behavioral Sciences. Dr. Merwin has expertise in eating disorders, Acceptance and Commitment Therapy (ACT), and psychological concerns in the management of Type 1 diabetes. She a Fellow and the current President of the Association for Contextual Behavioral Science, and 1 of 116 peer-reviewed ACT trainers worldwide. Dr. Merwin is leading work to address eating disorders in type 1 diabetes, a dangerous comorbidity that disproportionately affects women, and studies on the mechanisms of eating disorder development, maintenance and processes of change, and digital early interventions. Her research is funded by the National Institutes of Health (e.g., NIDDK, NIMH) and Breakthrough T1D (formerly the Juvenile Diabetes Research Foundation, JDRF), among other sponsors. Dr. Merwin is the author of ACT for Anorexia: A Guide for Clinicians. Her lab focuses on problematic eating and weight control, or more broadly, problems that arise from an adversarial relationship with the body or the body's cues, and/or difficulty reading and responding to internal cues to meet one's physical and emotional needs. Her treatment development work integrates digital and mobile technologies to increase treatment access and for momentary assessment and intervention. Dr. Merwin directs the ACT Clinic at Duke which provides clinical services in ACT and in-depth training in ACT for psychiatry residents, clinical psychology graduate students, interns and fellows. She also teaches a psychotherapy course for psychiatry residents in the School of Medicine and conducts continuing education events/workshops locally, nationally and internationally. For more information about Dr. Merwin's research, education and clinical activities, see ACTatDuke.org.
Current Appointments & Affiliations
Recent Publications
Acceptability and feasibility of acceptance and commitment therapy for improving outcomes in hematopoietic stem cell transplant.
Journal Article PLoS One · 2025 INTRODUCTION: Allogeneic hematopoietic stem cell transplant (HCT) has the potential to cure patients with hematologic malignancies, but treatment-related morbidity and mortality is high. Transplant outcomes are optimized by patients maintaining physical ac ... Full text Link to item CiteProfiles of disordered eating behaviour in type 1 diabetes using the DEPS-R and behaviour and glycaemic outcomes in a real-life setting.
Journal Article Diabet Med · June 2024 AIMS: The Diabetes Eating Problems Survey - Revised (DEPS-R) is commonly used to assess disordered eating behaviour (DEB) in individuals with type 1 diabetes and has advantages compared to other measures not specifically tailored to diabetes. A score ≥20 o ... Full text Link to item CitePredictors of changing patterns of adherence to containment measures during the early stage of COVID-19 pandemic: an international longitudinal study.
Journal Article Global Health · April 17, 2023 BACKGROUND: Identifying common factors that affect public adherence to COVID-19 containment measures can directly inform the development of official public health communication strategies. The present international longitudinal study aimed to examine wheth ... Full text Link to item CiteRecent Grants
FlexED: A Digital, Gamified Early Intervention for Eating Disorders based on Acceptance and Commitment Therapy
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2026A randomized controlled trial of iACT, a novel mHealth intervention for eating disorders in type 1 diabetes
ResearchPrincipal Investigator · Awarded by Juvenile Diabetes Research Foundation · 2022 - 2025North Carolina Diabetes Research Center Alzheimer's Supplement
ResearchCo-Principal Investigator · Awarded by Wake Forest University School Of Medicine · 2021 - 2022View All Grants